Silicon Valley Capital Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$353K Buy
5,625
+26
+0.5% +$2.08K 0.03% 75
2025
Q4
$534K Sell
5,599
-77
-1% -$7.55K 0.05% 66
2025
Q3
$554K Buy
5,676
+77
+1% +$7.97K 0.05% 61
2025
Q2
$601K Hold
5,599
0.06% 59
2025
Q1
$556K Sell
5,599
-150
-3% -$15.1K 0.07% 55
2024
Q4
$514K Hold
5,749
0.06% 59
2024
Q3
$482K Hold
5,749
0.06% 57
2024
Q2
$443K Hold
5,749
0.06% 57
2024
Q1
$394K Hold
5,749
0.06% 58
2023
Q4
$332K Hold
5,749
0.06% 57
2023
Q3
$304K Hold
5,749
0.06% 62
2023
Q2
$311K Buy
5,749
+150
+3% +$7.83K 0.06% 63
2023
Q1
$280K Hold
5,599
0.06% 63
2022
Q4
$259K Hold
5,599
0.06% 61
2022
Q3
$217K Hold
5,599
0.05% 62
2022
Q2
$209K Hold
5,599
0.04% 59
2022
Q1
$248K Hold
5,599
0.04% 63
2021
Q4
$238K Hold
5,599
0.04% 70
2021
Q3
$243K Hold
5,599
0.05% 61
2021
Q2
$239K Hold
5,599
0.05% 55
2021
Q1
$216K Hold
5,599
0.05% 62
2020
Q4
$201K Sell
5,599
-25
-0.4% -$901 0.04% 61
2020
Q3
$215K Buy
+5,624
New +$217K 0.05% 53
2020
Q1
Sell
-5,599
Closed -$253K 37
2019
Q4
$253K Hold
5,599
0.09% 35
2019
Q3
$228K Hold
5,599
0.09% 33
2019
Q2
$241K Hold
5,599
0.1% 31
2019
Q1
$215K Buy
+5,599
New +$214K 0.09% 32
2018
Q4
Sell
-5,599
Closed -$216K 27
2018
Q3
$216K Buy
+5,599
New +$196K 0.09% 25

Other funds holding BSX

Silicon Valley Capital Partners's BSX Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its Boston Scientific (BSX) stake by 0.46% in Q1 2026, buying an estimated $2.08K and bringing the position to 5,625 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #75.

Silicon Valley Capital Partners first reported a position in BSX in Q3 2018 and has held it in 28 quarters since. The position peaked at $601K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Silicon Valley Capital Partners held 5,625 shares of Boston Scientific worth $353K as of Q1 2026.
  • Silicon Valley Capital Partners bought 26 Boston Scientific shares in Q1 2026, an estimated $2.08K.
  • Boston Scientific made up 0.03% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #75 holding.
  • Silicon Valley Capital Partners first reported a position in Boston Scientific in Q3 2018 and has held it in 28 quarters since.
  • Silicon Valley Capital Partners's Boston Scientific position peaked at $601K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.